Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Smoking Cessation 3Smoking 2Neoplasms 2Lung Neoplasms 2Alcohol Drinking 2Urinary Bladder Neoplasms 1Smokers 1Postoperative Complications 1Cigarette Smoking 1Cigarette Smoker 1Carcinoma, Non-Small-Cell Lung 1Cancer Free Women 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 31Pemetrexed 28Radiotherapy 22Bevacizumab 21Cisplatin 20Gemcitabine 18Paclitaxel 17Erlotinib Hydrochloride 15Docetaxel 12Gefitinib 8Nivolumab 6Mastectomy, Segmental 6Magnetic Resonance Spectroscopy 6pembrolizumab 5aflutinib 5Radiosurgery 5tislelizumab 4Vinorelbine 4Surgical Procedures, Operative 4Specimen Handling 4Sorafenib 4Platinum 4Metformin 4Biopsy 42-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 4sargramostim 3apatinib 3Taxes 3Cetuximab 3Anterior Temporal Lobectomy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma of Lung × Smoking Devices × Clear all
NCT03199651 2026-02-19

BLCIO

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
3,584 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡